Literature DB >> 26171630

Gluten-free diet or alternative therapy: a survey on what parents of celiac children want.

Lorenzo Norsa1, Carolina Tomba, Carlo Agostoni, Federica Branchi, Maria Teresa Bardella, Leda Roncoroni, Dario Conte, Luca Elli.   

Abstract

OBJECTIVES: Celiac disease (CD) is treated by life-long gluten-free diet (GFD). Novel therapies are under development. Willingness of CD children's parents to alternative therapies and GFD impact were evaluated.
METHODS: Parents of celiac children on GFD were investigated on need and preference for novel CD therapies, children's enrolment in trials, compliance to and personal judgment on GFD, health status (HS) and quality of life (QoL).
RESULTS: About 59.5% surveyed parents expressed the need for alternative therapies with a preference for vaccine-based strategy (39.9%). About 37.7% would accept enrollment in an ad hoc trial, 20.3% would agree to endoscopy during the trial. GFD compliance was 97.4% and well accepted by 93.8%. HS and QoL significantly improved during GFD (p < 0.001).
CONCLUSIONS: The introduction of novel therapies for CD is desirable for over half of parents, with preference for vaccines. Parents frown upon enrolment in new clinical trials and the subsequent need for additional endoscopy.

Entities:  

Keywords:  Celiac disease; gastroenterology; nutrition; pediatrics

Mesh:

Substances:

Year:  2015        PMID: 26171630     DOI: 10.3109/09637486.2015.1064872

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  7 in total

1.  Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.

Authors:  Guoxian Wei; Na Tian; Roland Siezen; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-28       Impact factor: 4.052

Review 2.  Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments.

Authors:  Francesco Valitutti; Alessio Fasano
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

3.  Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.

Authors:  Martial Rey; Menglin Yang; Linda Lee; Ye Zhang; Joey G Sheff; Christoph W Sensen; Hynek Mrazek; Petr Halada; Petr Man; Justin L McCarville; Elena F Verdu; David C Schriemer
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

Review 4.  Celiac disease: From pathophysiology to treatment.

Authors:  Ilaria Parzanese; Dorina Qehajaj; Federica Patrinicola; Merica Aralica; Maurizio Chiriva-Internati; Sanja Stifter; Luca Elli; Fabio Grizzi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

Review 5.  Celiac Disease and the Microbiome.

Authors:  Francesco Valitutti; Salvatore Cucchiara; Alessio Fasano
Journal:  Nutrients       Date:  2019-10-08       Impact factor: 5.717

Review 6.  A Systematic Review on Gluten-Free Bread Formulations Using Specific Volume as a Quality Indicator.

Authors:  Jordanna S Monteiro; Priscila Farage; Renata Puppin Zandonadi; Raquel B A Botelho; Livia de L de Oliveira; António Raposo; Faiyaz Shakeel; Sultan Alshehri; Wael A Mahdi; Wilma M C Araújo
Journal:  Foods       Date:  2021-03-13

Review 7.  Contribution of Infectious Agents to the Development of Celiac Disease.

Authors:  Daniel Sánchez; Iva Hoffmanová; Adéla Szczepanková; Věra Hábová; Helena Tlaskalová-Hogenová
Journal:  Microorganisms       Date:  2021-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.